This condition mimics true hypoxia by increasing the intracellular reduced and oxidized nicotinamide adenine dinucleotide (NADH/NAD) ratio, thereby disrupting cellular redox homeostasis
In astudyinvolving rats, BPC-157 was administered in doses of 0, 0.1, 0.25, and 0.5 micrograms/mL over 24 hours. Results showed that the 0.5 microgram/mL dose significantly increased growth hormone expression from day 1 to day 3, while lower doses also had similar effects. The study concluded that BPC-157 supplementation led to increased up-regulation of growth hormone in a dose and time-dependent manner
Testing reduces risk but does not eliminate it
Some women continued using HerSolution past the third month, while others decided to stop after the end of the third month because they were content with the results
However, their use is not without adverse effects, particularly gastrointestinal disturbances, which can impact treatment adherence and patient satisfaction [6]